Breaking News, Collaborations & Alliances

PrecisionLife Enters Multi-Target R&D Partnership with Ono Pharmaceutical

Will identify novel therapeutic targets and patient stratification biomarkers in central nervous system (CNS) disorders for development by Ono.

Author Image

By: Charlie Sternberg

Associate Editor

PrecisionLife Limited, a global techbio company generating insights into disease biology to create novel precision medicines in chronic diseases, has entered into a multi-target discovery and validation partnership with Ono Pharmaceutical Co., Ltd., an R&D-orientated pharmaceutical company.   The R&D collaboration will leverage PrecisionLife’s combinatorial analytics-generated insights to identify novel therapeutic targets and patient stratification biomarkers in central nervous system...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters